FDA to review Takeda's resubmission of Budesonide oral suspension - NDA of TAK-721, offering new hope for Eosinophilic Oesophagitis (EoE) patients. What does this mean for the eosinophilic community? Read more
Recent research shows weekly dupilumab outperforms bi-weekly treatments in managing Eosinophilic Oesophagitis (EoE) symptoms. Read more
Learn how groundbreaking research on Thymic Stromal Lymphopoietin (TSLP) offers hope for more effective and less invasive diagnoses and treatments for eosinophilic diseases like EoE. Read more
Eosinophilic Awareness Month ended with our gratitude for support. Through Eosinophilic Voices and collaborations, we raised awareness and facilitated early recognition of symptoms. Your support is vital in achieving our mission for prompt diagnosis, treatment, and holistic care for EAD patients. Read more
Explore new research findings on how FLIP panometry can be used to classify Eosinophilic Esophagitis (EoE) patients by disease severity. This innovative method could pave the way for personalised treatment plans, improving patient outcomes. Read more
Recent findings highlight an association between achalasia and Eosinophilic Esophagitis (EoE) in 6.5% of achalasia patients. Understanding this rare link may improve treatment options for both conditions, potentially benefiting those with EoE and achalasia. Read more
A recent multi-centred study reveals removing just animal milk as first-line diet therapy for EoE Eosinophilic Oesophagitis is equally effective in the 6-week trial. Read more
A Charter outlining the key rights and expectations for people living with eosinophil-associated diseases. It proposes four key principles that will patients should expect from the management of their conditions and set a basic standardisation of care. Read more
A publication in Clinical Gastroenterology and Hepatology has made an important step towards developing international consensus for EGID terminology. Read more
Celebrate European Eosinophilic Oesophagitis Day, raising awareness of EoE and dysphagia. Learn about eosinophilic diseases, challenges in diagnosis and treatment, and initiatives to improve patients' lives. Read more
On May 18th, we celebrate Eosinophilic Associated Diseases EADs to bring attention to these rare life-impacting conditions. Learn about EAD symptoms, management, and how EOS Network advocates for improved care. Read more
A new study offers insight into the role of early life exposures like pregnancy complications or antibiotics, as risk factors for non-oesophageal eosinophilic gastrointestinal diseases (non-EoE EGIDs). Read more
The EOS Network participated in a significant paediatric gastroenterology event, advocating for better care for eosinophilic disease patients. We distributed information packs to healthcare professionals and established valuable connections, raising awareness and promoting a patient-centric approach. Read more
The study shows adjusting a topical swallow steroid regimen can help manage adrenal insufficiency in children with Eosinophilic Oesophagitis EoE, but this may come at the expense of disease control. Read more
A study reveals the importance of IL-13 signalling in Eosinophilic Oesophagitis (EoE) and suggests potential new treatment approaches targeting the IL-4 receptor. Read more
Phase 2 trial shows benralizumab induces histological remission in 77% of eosinophilic gastritis patients, but further research on other immune pathways is needed Read more
Discover the efficacy of fluticasone oral disintegrating tablet in treating eosinophilic esophagitis (EoE) based on a randomised phase 2 controlled trial. Read more
The latest USA guidance on the use of dupilumab in EoE. Insights into when and how to consider dupilumab as a first-line or step-up therapy, shared decision-making approach and monitoring outcomes. Read more
ausEE Inc., Australia's leading support organisation for eosinophilic diseases, is hosting its 11th National EOS Awareness Week from 6-12 August 2023. The event raises awareness about eosinophilic gastrointestinal diseases, focusing on EoE. Read more
Sean Goss is a professional footballer with EoE. His journey will be familiar to many living with the condition - adapting lifestyle and struggling to find a correct diagnosis. We're proud to have him as an ambassador for our charity. Read more
An Italian study has found that paediatric patients with Eosinophilic Gastrointestinal Diseases EGIDs were prone to be underweight. Symptoms associated with their EGIDs were impeding their weight gain but going undiagnosed. Read more
Discover the latest findings on oral immunotherapy (OIT) for children with food allergies and its link to eosinophilic esophagitis (EoE). Learn about the study's methods, results, and implications for patient care. Read more
Dupilumab has been recommended for EU approval by the CHMP for the treatment of eosinophilic oesophagitis (EoE). It is the first biologic drug in the EU indicated for EoE for sufferers aged 12+. Read more
New Eosinophilic Oesophagitis EoE Paediatric to Adult Comprehensive Medical Diagnosis and Care Guidelines Read more